265 Aufrufe 265 0 Kommentare 0 Kommentare

    CVS Investors Have Opportunity to Join CVS Health Corporation Fraud Investigation with the Schall Law Firm

    The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corporation (“CVS” or “the Company”) (NYSE: CVS) for violations of the securities laws.

    The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. CVS failed to properly forecast medical cost trends and health care utilization rates. The Company was forced to incur material costs due to its ineffective forecasts. The Company overstated the profitability of its Health Care Benefits division. Despite its assurances, the Company’s profits from other business segments were not sufficient to cover the increasing expenses incurred by the Health Care Benefits segment. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about CVS, investors suffered damages.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu CVS Health!
    Short
    71,76€
    Basispreis
    0,44
    Ask
    × 14,06
    Hebel
    Zum Produkt
    Long
    60,65€
    Basispreis
    0,67
    Ask
    × 9,24
    Hebel
    Zum Produkt
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    If you are a shareholder who suffered a loss, click here to participate.

    We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

    The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

    This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.


    The CVS Health Stock at the time of publication of the news with a raise of +0,31 % to 51,31USD on Tradegate stock exchange (10. September 2024, 17:51 Uhr).

    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    CVS Investors Have Opportunity to Join CVS Health Corporation Fraud Investigation with the Schall Law Firm The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corporation (“CVS” or “the Company”) (NYSE: CVS) for violations of the securities laws. The …